Allakos Inc (ALLK)
$1.06
Insights on Allakos Inc
Vs NVO
In the last 1 year, Novo Nordisk A/s has given 46.7% return, outperforming this stock by 121.1%
Vs NVO
In the last 3 years, Novo Nordisk A/s has given 245.1% return, outperforming this stock by 344.1%
Performance
- $1.03$1.12$1.06
3.3%
Downside
Day's Volatility :8.48%
Upside
5.36%
- $1.00$5.64$1.06
5.66%
Downside
52 Weeks Volatility :82.27%
Upside
81.21%
Returns
| Period | Allakos Inc | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | -2.75% | -0.7% | 0.0% |
6 Months | -44.79% | 6.6% | 0.0% |
1 Year | -74.4% | 3.7% | -1.5% |
3 Years | -98.99% | 14.0% | -21.8% |
Highlights
Market Capitalization | 92.3M |
Book Value | $1.92 |
Earnings Per Share (EPS) | -2.14 |
Wall Street Target Price | 2.9 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -38.9% |
Return On Equity TTM | -77.5% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -189.9M |
Diluted Eps TTM | -2.14 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.2 |
EPS Estimate Next Year | -0.7 |
EPS Estimate Current Quarter | -0.47 |
EPS Estimate Next Quarter | -0.5 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 173.58%
Technicals Summary
Sell
Neutral
Buy
Allakos Inc is currently in a neutral trading position according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Allakos Inc | -13.82% | -44.79% | -74.4% | -98.99% | -97.18% |
 Moderna, Inc. | -0.79% | 20.27% | -27.48% | -36.11% | 359.53% |
 Regeneron Pharmaceuticals, Inc. | -6.12% | 9.1% | 11.53% | 80.35% | 170.35% |
 Novo Nordisk A/s | -6.29% | 23.82% | 46.7% | 242.59% | 414.69% |
 Vertex Pharmaceuticals Incorporated | -4.44% | 6.95% | 20.9% | 79.35% | 133.77% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Allakos Inc | NA | NA | NA | -1.2 | -0.77 | -0.39 | NA | 1.92 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.22 | -0.29 | -0.12 | NA | 36.27 |
Regeneron Pharmaceuticals, Inc. | 25.71 | 25.71 | 1.46 | 45.13 | 0.16 | 0.08 | NA | 242.47 |
Novo Nordisk A/s | 46.58 | 46.58 | 2.4 | 3.33 | 0.88 | 0.23 | 0.01 | 23.9 |
Vertex Pharmaceuticals Incorporated | 28.42 | 28.42 | 0.53 | 16.73 | 0.23 | 0.13 | NA | 68.22 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Allakos Inc | Buy | $92.3M | -97.18% | NA | 0.0% |
Moderna, Inc. | Buy | $39.8B | 359.53% | 24.73 | -68.84% |
Regeneron Pharmaceuticals, Inc. | Buy | $98.1B | 170.35% | 25.71 | 30.14% |
Novo Nordisk A/s | Buy | $551.2B | 414.69% | 46.58 | 36.03% |
Vertex Pharmaceuticals Incorporated | Buy | $101.9B | 133.77% | 28.42 | 36.68% |
Institutional Holdings
Bvf Inc
9.73%T. Rowe Price Associates, Inc.
9.01%NEA Management Company, LLC
7.00%BlackRock Inc
5.82%RiverVest Venture Management LLC
5.68%Citadel Advisors Llc
4.72%
Corporate Announcements
Allakos Inc Earnings
Allakos Inc’s price-to-earnings ratio stands at None
Read More
Company Information
allakos inc is a biotechnology company located in 7400 paseo padre pkwy, fremont, ca, united states.
Organization | Allakos Inc |
Employees | 131 |
CEO | Dr. Robert Alexander Ph.D. |
Industry | Health Technology |
